Search for: "MG Novelty Company" Results 1 - 7 of 7
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Jan 2019, 8:32 am
In early 2000, Helsinn submitted protocols for Phase III clinical trials to the Food and Drug Administration (FDA), proposing to study a 0.25 mg and a 0.75 mg dose of palonosetron. [read post]
31 Oct 2017, 12:05 am
Limited and others v Yeda Research and Development Company Limited and others [2017] EWHC 2629 (Pat) - the first application of Actavis v Eli Lilly in the Patents Court. [read post]
21 Apr 2011, 3:01 pm by Oliver G. Randl
“BABYPLAST Yellow 5GN 01”, however, is a pigment preparation, i.e. a product that is delivered to processing companies which use this product for manufacturing coloured intermediate or end products. [read post]
15 Mar 2019, 9:47 am by Sander van Rijnswou
Novelty (Article 100(a) and Article 54(1) EPC)Document (1) does not provide a direct and unambiguous disclosure of the feature of intramuscular injection and is thus not novelty-destroying for the subject-matter of claim 1.(...)5. [read post]
3 Mar 2017, 7:25 am
The High Court has granted declarations to FKB and SB to the effect that their products lacked novelty or an inventive step at a particular date - Fujifilm Kyowa Kirin Biologics Company Limited and Samsung Bioepsis UK Limited v AbbVie Biotechnology Limited [2017] EWHC 395 (Pat). [read post]
1 Jul 2012, 2:54 am
T 0134/10 A patent in the name of Colgate-Palmolive Company relating to pearlised cleansing compositions was opposed by The Procter & Gamble Company and Sasol Germany GmbH. [read post]
2 Feb 2018, 1:31 pm by Gregory Sephton
  Because the third-party company also was small, its Helsinn agreement was a “material” contract for the third-party company under US securities regulations, which required that it be publicly disclosed. [read post]